Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01286077 · BASELINE

Baseline characteristics

Velcade Consolidation Bone Study · Source last updated 2016-05-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      51
    2. group Id
      BG001
      value
      53
    3. group Id
      BG002
      value
      104
    units
    Participants
groups
  1. description
    bortezomib (Velcade) 1.6 mg/m² bolus injection on Days 1, 8, 15 and 22 every 5 weeks for 4 cycles
    id
    BG000
    title
    Bortezomib
  2. description
    no treatment, observation only
    id
    BG001
    title
    Non-treated Control
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          27
          upper Limit
          75
          value
          56.7
        2. group Id
          BG001
          lower Limit
          35
          upper Limit
          73
          value
          54.7
        3. group Id
          BG002
          lower Limit
          27
          upper Limit
          75
          value
          55.7
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          18
        2. group Id
          BG001
          value
          22
        3. group Id
          BG002
          value
          40
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          33
        2. group Id
          BG001
          value
          31
        3. group Id
          BG002
          value
          64
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      51
    2. group Id
      BG001
      value
      53
    3. group Id
      BG002
      value
      104
    units
    Participants
groups
  1. description
    bortezomib (Velcade) 1.6 mg/m² bolus injection on Days 1, 8, 15 and 22 every 5 weeks for 4 cycles
    id
    BG000
    title
    Bortezomib
  2. description
    no treatment, observation only
    id
    BG001
    title
    Non-treated Control
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          27
          upper Limit
          75
          value
          56.7
        2. group Id
          BG001
          lower Limit
          35
          upper Limit
          73
          value
          54.7
        3. group Id
          BG002
          lower Limit
          27
          upper Limit
          75
          value
          55.7
    dispersion Type
    FULL_RANGE
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          18
        2. group Id
          BG001
          value
          22
        3. group Id
          BG002
          value
          40
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          33
        2. group Id
          BG001
          value
          31
        3. group Id
          BG002
          value
          64
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice